You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 November 2026 - Norwegian bladder cancer diagnostics company Photocure ASA (OSE: PHO) said on Wednesday that it has signed an agreement with pharmaceutical services provider Clinigen to supply Hexvix through a Named Patient Program (NPP) in more t...
18 November 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) announced on Wednesday that it has entered into an exclusive licensing agreement with biotechnology company Starna Therapeutics to develop and commercialise three preclinical in vi...
18 November 2026 - DDL, a third-party testing laboratory specialising in medical device and pharmaceutical packaging, combination products, and materials testing, announced on Tuesday that it has launched a new Pharmaceutical Consulting Services prog...
18 November 2026 - Ichnos Glenmark Innovation Inc (IGI), a clinical-stage biotechnology company focused on developing Multispecific therapeutics in oncology, announced on Tuesday the submission of an Investigational New Drug (IND) application to the ...
18 November 2026 - Inhibrx Biosciences Inc (Nasdaq:INBX), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, announced on Tuesday updated clinical data from the Phase 1/2 expansion study evaluating...
18 November 2026 - Clinical-stage oncology company Onward Therapeutics Inc announced on Tuesday that it has closed its Series B financing of NTD900m (approximately USD28m).The round was raised in two closings, the second of which took place in Octobe...
17 November 2026 - Norwegian biotech company Oncoinvent ASA (OSE:ONCIN) on Tuesday reported favourable safety and tolerability results from the first interim safety analysis of its randomised phase 2 trial evaluating Radspherin in patients with advan...